Gammie et al. characterized 54 MSH2 variants associated with hereditary nonpolyposis colorectal cancer showing that about half of the variants have enzymatic function but are targeted for degradation (Gammie et al., 2007). The gene discussed is MSH2; the disease is hereditary nonpolyposis colon cancer.